55513-0141 Kanjinti - CanMED: NDC

Product NDC:

55513-0141

Brand Name:

Kanjinti

Generic Name:

trastuzumab-anns

Dosage Form Name:

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Administration Route:

Intravenous

Substances:

Name: TRASTUZUMAB

Strength: 150.0

Unit: mg/7.15mL

Packages:

Code: 55513-0141-01

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-141-01) / 7.15 mL in 1 VIAL, SINGLE-DOSE

Effective Date: Oct. 28, 2019

Discontinued:

Code: 55513-0141-21

Description: 1 VIAL, SINGLE-DOSE in 1 CARTON (55513-141-21) / 7.15 mL in 1 VIAL, SINGLE-DOSE

Effective Date: July 1, 2025

Discontinued:

SEER*Rx Category:

Immunotherapy

Major Class:

Monoclonal Antibody

Minor Class:

HER2

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox